Digestive and Liver Disease
Volume 42, Issue 7 , Pages 515-519 , July 2010

Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: Survival rate and prognostic factors

  • Mirko Olivo

      Affiliations

    • Medicine, Pneumatology and Nutrition Physiology Clinic, “V. Cervello” Hospital, Palermo University, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 03474997540; fax: +39 0916885111.
  • ,
  • Franco Valenza

      Affiliations

    • Radiology Department, V. Cervello Hospital, Palermo, Italy
  • ,
  • Antonio Buccellato

      Affiliations

    • Radiology Department, V. Cervello Hospital, Palermo, Italy
  • ,
  • Lorenza Scala

      Affiliations

    • Medicine, Pneumatology and Nutrition Physiology Clinic, “V. Cervello” Hospital, Palermo University, Italy
  • ,
  • Roberto Virdone

      Affiliations

    • Medicine, Pneumatology and Nutrition Physiology Clinic, “V. Cervello” Hospital, Palermo University, Italy
  • ,
  • Elio Sciarrino

      Affiliations

    • Medicine, Pneumatology and Nutrition Physiology Clinic, “V. Cervello” Hospital, Palermo University, Italy
  • ,
  • Sonia Di Piazza

      Affiliations

    • Gastroenterology Department, “V. Cervello” Hospital, Palermo, Italy
  • ,
  • Ciro Marrone

      Affiliations

    • Medicine, Pneumatology and Nutrition Physiology Clinic, “V. Cervello” Hospital, Palermo University, Italy
  • ,
  • Ambrogio Orlando

      Affiliations

    • Medicine, Pneumatology and Nutrition Physiology Clinic, “V. Cervello” Hospital, Palermo University, Italy
  • ,
  • Giorgio Fusco

      Affiliations

    • Medicine, Pneumatology and Nutrition Physiology Clinic, “V. Cervello” Hospital, Palermo University, Italy
  • ,
  • Salvatore Madonia

      Affiliations

    • Medicine, Pneumatology and Nutrition Physiology Clinic, “V. Cervello” Hospital, Palermo University, Italy
  • ,
  • Mario Cottone

      Affiliations

    • Medicine, Pneumatology and Nutrition Physiology Clinic, “V. Cervello” Hospital, Palermo University, Italy

Received 10 March 2009 ,Accepted 30 September 2009.

References 

  1. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. 1.0 ed.. Lyon: IARC Press; 2001;
  2. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–156
  3. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421–430
  4. Bruix J, Morris S. Management of hepatocellular carcinoma. Hepatology. 2005;1208–2005
  5. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917
  6. Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology. 2004;127:S179–S188
  7. Lubienski A. Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation. 2005;80:S113–S119
  8. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases . Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236
  9. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429–442
  10. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–1171
  11. Cammà C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology. 2002;224:47–54
  12. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with 178 unresectable hepatocellular carcinoma: a randomized trial. Lancet. 2002;359:1734–1739
  13. Seldinger SI. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta Radiol. 1953;39:368–376
  14. Kaplan EI, Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457–481
  15. Christensen E. Multivariate survival analysis using Cox's regression model. Hepatology. 1987;7:1346–1358
  16. Takayasu K, Arii S, Ikai I, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006;131:461–469
  17. Dumortier J, Chapuis F, Borson O, et al. Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients. Digest Liver Dis. 2006;38:125–133
  18. Hiraoka A, Kumagi T, Hirooka M, et al. Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatment. World J Gastroenterol. 2006;12:2075–2079
  19. Hayashi K, Ina H, Tezuka M, et al. Local Therapeutic results of computed tomography-guided transcatheter chemoembolization for hepatocellular carcinoma: results of 256 tumors in 79 patients. Cardiovasc Intervent radiol. 2007;30:1144–1155
  20. Savastano S, Miotto D, Casarrubea G, et al. Transcatheter chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol. 1999;28:334–340
  21. Lladò L, Virgili J, Figueras J, et al. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter chemoembolization. Cancer. 2000;88:50–57
  22. Biselli M, Andreone P, Gramenzi A, et al. Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study. Clin Gastroenterol Hepatol. 2005;3:918–925
  23. Shen H, Agarwal D, Qi R, et al. Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization. Aliment Pharmacol Ther. 2007;26:393–400
  24. Kim JH, Kim JH, Choi JH, et al. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. Scand J Gastroenterol. 2009;44:346–357
  25. Miraglia R, Pietrosi G, Maruzzelli L, et al. Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: a multivariate analysis of pre findings. World J Gastroenterol. 2007;13:6022–6026
  26. Sala M, Llovet JM, Vilana R, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology. 2004;40:1352–1360
  27. Licata A, Di Marco V, Parisi P, et al. Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center. Minerva Gastroenterol Dietol. 2005;51:171–178
  28. Camma C, Di Marco V, Orlando A, et al. Unita Interdipartimentale Neoplasie Epatiche (U.I.N.E) Group. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol. 2005;42:535–540
  29. Lin SM, Lin CJ, Lin CC, et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, percutaneous acetic acid injection to treat hepatocellular carcinoma of 3cm or less. Gut. 2005;54:1151–1156[Erratum in: Gut 2005;54(October (10)):1508]
  30. Sacco R, Bertini M, Petruzzi P, et al. Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: a cohort study. World J Gastroenterol. 2009;15:1843–1849
  31. Matsui O, Kadoya M, Yoshikawa J, et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology. 1993;188:79–83
  32. Li L, Wu PH, Li JQ, et al. Segmental transctheter arterial embolization for primary hepatocellular carcinoma. World J Gastroenterol. 1998;4:511–512

PII: S1590-8658(09)00419-8

doi: 10.1016/j.dld.2009.09.012

Digestive and Liver Disease
Volume 42, Issue 7 , Pages 515-519 , July 2010